{"disease":{"id":"platinum-resistant-recurrent-clear-cell-ovarian-cancer","name":"platinum resistant recurrent clear cell ovarian cancer"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05130515","title":"Anlotinib Combined With Niraparib Dual Therapy in Platinum-resistant Recurrent Ovarian Clear Cell Carcinoma.","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":6,"lead_sponsor_name":"Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}